REFERENCES
  1. Tapper EB, Lok ASF. Use of Liver Imaging and Biopsy in Clinical Practice. N Engl J Med. 2017;377(23):2296-2297. doi: 10.1056/NEJMc1712445.
  2. Younossi ZM, Teran JC, Ganiats TG, Carey WD. Ultrasound-guided liver biopsy for parenchymal liver disease: and economic analysis. Dig Dis Sci. 1998;43(1):46-50. doi: 10.1023/a:1018815802500.
  3. Lindor KD, Bru C, Jorgensen RA, Rakela J, Bordas JM, Gross JB, et al. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology. 1996;23(5):1079-1083. doi: 10.1002/hep.510230522.
  4. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver Biopsy.Hepatology. 2009;49(3):1017-1044. doi: 10.1002/hep.22742.
  5. Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int. 2008;28(5):705-712. doi: 10.1111/j.1478-3231.2008.01691.x.
  6. DiTeodoro LA, Pudhota SG, Vega KJ, Jamal MM, Munoz JC, Wludyka P, et al. Ultrasound marking by gastroenterologists prior to percutaneous liver biopsy removes the need for a separate radiological evaluation.Hepatogastroenterology. 2013;60(124):821-824. doi: 10.5754/hge121106.
  7. Filingeri V, Sforza D, Tisone G. Complications and risk factors of a large series of percutaneous liver biopsies in patients with liver transplantation or liver disease. Eur Rev Med Pharmacol Sci.2015;19(9):1621-1629
  8. Parente FVC, Moura EA, Santos JAM, Lima MVA. US-Guided percutaneous core liver biopsy: Analysis of 171 cases from a single oncology service. Arq Gastroenterol. 2018;55(3):208-211. doi: 10.1590/S0004-2803.201800000-55.
  9. Patel NJ, Bowman AW. Assessment of Appropriate Recovery Time After Liver Biopsy. J Am Coll Radiol. 2018;15(9):1266-1268. doi: 10.1016/j.jacr.2018.04.004.
  10. Bravo AA, Sheth SG, Chopra S. Liver Biopsy. N Engl J Med.2001;344(7):495-500. doi: 10.1056/NEJM200102153440706.
  11. Taykar V, Etzion O, Heller T, Kleiner DE, Rotman Y, Ghany MG, et al. Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience. Aliment Pharmacol Ther.2017;45(5):744-753. doi: 10.1111/apt.13939
  12. Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K. The role of liver biopsy in chronic hepatitis C. Hepatology.2001;33(1):196-200. doi: 10.5114/ceh.2016.58851.
  13. Jarcuska P, Bruha R, Horvath G, Simon K, Drazilova S. Evaluation of hepatic fibrosis – access to non-invasive methods, national practice/guidelines in Central Europe. Clin Exp Hepatol.2016;2(1):12-15. doi: 10.5114/ceh.2016.58851.
  14. Eisenberg E, Konopniki M, Veitsman E, Kramskay R, Gaitini D, Baruch Y. Prevalence and Characteristics of Pain Induced by Percutaneous Liver Biopsy. Anesth Analg. 2003;96(5):1392-1396. doi: 10.1213/01.ane.0000060453.74744.17.
  15. Kose S, Ersan G, Tatar B, Adar P, Sengel BE. Evaluation of Percutaneous Liver Biopsy Complications in Patients with Chronic Viral Hepatitis. Eurasian J Med. 2015;47(3):161-164. doi: 10.5152/eurasianjmed.2015.107.
  16. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012 ;30(12):2212-2219. doi: 10.1016/j.vaccine.2011.12.116.
  17. Cakmakci E, Caliskan KC, Tabakci ON, Tahtabasi M, Karpat Z. Percutaneous liver biopsies guided with ultrasonography: a case series. Iran J Radiol. 2013;10(3):182-184. doi: 10.5812/iranjradiol.13184.
  18. Filingeri V, Francioso S, Sforza D, Santopaolo F, Oddi FM, Tisone G. A retrospective analysis of 1.011 percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications? Eur Rev Med Pharmacol Sci. 2016;20(17):3609-3617.
  19. Almeida P, Schreiber RA, Liang J, Mujawar Q, Guttman OR. Clinical characteristics and complications of pediatric liver biopsy: a single centre experience. Ann Hepatol. 2017;16(5):797-801. doi: 10.5604/01.3001.0010.2809.
  20. Costa RS, Cardoso AF, Ferreira A, Costa J, Costa D, Fernandes D, et al. What recovery position should patients adopt after percutaneous liver biopsy? Eur J Gastroenterol Hepatol. 2019;31(2):253-259. doi: 10.1097/MEG.0000000000001290.
  21. McCarty TR, Bazarbashi NA, Njei B, Ryou M, Aslanian HR, Muniraj T. Endoscopic Ultrasound-Guided, Percutaneous, and Transjugular Liver Biopsy: A Comparative Systematic Review and Meta-Analysis. Clin Endosc. 2020;53(5):583-593. doi: 10.5946/ce.2019.211.
  22. Bolia R, Matta J, Malik R, Hardikar W. Outpatient Liver Biopsy in Children: Safety, Feasibility, and Economic Impact. J Pediatr Gastroenterol Nutr. 2017;65(1):86-88. doi: 10.1097/MPG.0000000000001565.
  23. Hayatghaibi S, Ashton D, Cleveland H, Kukreja K. Limited Post-observation Period in Pediatric Outpatient Ultrasound-Guided Liver Biopsies. Cardiovasc Intervent Radiol.2017;40(12):1899-1903. doi: 10.1007/s00270-017-1720-3.
  24. Van der Poorten D, Kwok A, Lam T, Ridley L, Jones DB, Ngu MC, et al. Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital. Intern Med J. 2006;36(11):692-699. doi: 10.1111/j.1445-5994.2006.01216.x.
  25. Midia M, Odedra D, Shuster A, Midia R, Muir J. Predictors of bleeding complications following percutaneous image-guided liver biopsy: a scoping review. Diagn Interv Radiol. 2019;25(1):71-80. doi: 10.5152/dir.2018.17525.
  26. Thampanitchawong P, Piratvisuth T. Liver biopsy: complications and risk factors. World J Gastroenterol. 1999;5(4):301-304. doi: 10.3748/wjg.v5.i4.301.
  27. Seeff LB, Everson GT, Morgan TR, Curto TM, Lee WM, Ghany MG, et al. HALT–C Trial Group. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.Clin Gastroenterol Hepatol. 2010;8(10):877-883. doi: 10.1016/j.cgh.2010.03.025.
  28. tenBerge J, Hoffman BJ, Hawes RH, Enckevort CV, Giovannini M, Erickson RA, et al. EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc. 2002;55(7):859-862. doi: 10.1067/mge.2002.124557
  29. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London.Gut. 1995;36(3):437-441 doi: 10.1136/gut.36.3.437.
  30. Manolakopoulos S, Triantos C, Bethanis S, Theodoropoulos J, Vlachogiannakos J, Cholongitas E, et al. Ultrasound-guided liver biopsy in real life: comparison of same-day prebiopsy versus real-time ultrasound approach. J Gastroenterol Hepatol.2007;22(9):1490-1493. doi: 10.1111/j.1440-1746.2007.04992.x.
  31. Westheim BH, Aagenæs I, Østensen AB, Sanengen T, Almaas R. Effect of operator experience and frequency of procedure performance on complication rate after ultrasound-guided percutaneous liver biopsies.J Pediatr Gastroenterol Nutr. 2013;57(5):638-643. doi: 10.1097/MPG.0b013e3182a0c7a5.